Marta
Segarra Montaner
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (1)
2013
-
Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 9, pp. 1481-1487